A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2011
05/18/2011	EP2320729A1 Glycoside compounds and pharmaceutical compositions thereof
05/18/2011	EP2320728A1 Taxane compounds for treating eye disease
05/18/2011	EP2320725A1 Use of plant growth regulators to reduce abscisic acid related plant leaf yellowing
05/18/2011	EP2158194B1 Derivatives of 7-alkynyl-1,8-naphthyridones, preparation method thereof and use of same in therapeutics
05/18/2011	EP2129672B1 Azaadamantane ester and carbamate derivatives and methods of use thereof
05/18/2011	EP2101762B1 Novel 2 -imidazoles as ligands for trace amine associated receptors (taar)
05/18/2011	EP2101571B1 Ornithine conjugates of amphetamine and processes for making and using the same
05/18/2011	EP2099759B1 Antibacterial quinoline derivatives
05/18/2011	EP2091949B1 Indole derivatives as s1p1 receptor agonists
05/18/2011	EP2091944B1 Substituted bicyclocarboxyamide compounds
05/18/2011	EP2089024B1 Combination of iap inhibitors and flt3 inhibitors
05/18/2011	EP2079709B1 Substituted 2-phenyl-benzimidazoles and their use as pharmaceuticals
05/18/2011	EP2076502B1 Substituted carboxamides as group i metabotropic receptor antagonists
05/18/2011	EP2069339B1 Substituted piperidinophenyl oxazolidinones
05/18/2011	EP2054045B1 Use of 2,5-dihydroxybenzene derivatives for the treatment of arthritis and pain
05/18/2011	EP2046779B1 Modulators of chemokine receptor activity, crystalline forms and process
05/18/2011	EP2040755B1 Combination of a cholinesterase inhibitor and a compound with 5-ht6 receptor affinity
05/18/2011	EP2034967B1 Oral pharmaceutical composition of a poorly water-soluble active substance
05/18/2011	EP1984501B1 Mcp-i binding nucleic acids
05/18/2011	EP1984324B1 Mandelic hydrazides
05/18/2011	EP1943232B1 Squaric acid derivatives as inhibitors of histone deacetylase
05/18/2011	EP1919920B1 Pentacyclic kinase inhibitors
05/18/2011	EP1861404B1 Polymorphic form of 6- (4-chlorophenyl) -2, 2-dimethyl-7-phenyl-2, 3-dihydro-lh-pyrrolizin-5-ylacetic acid
05/18/2011	EP1848709B1 Novel salt form of a dopamine agonist
05/18/2011	EP1796688B1 Pancreatic cancer treatment using na+/k+ atpase inhibitors
05/18/2011	EP1786397B1 Phenytoin formulations, and uses thereof in wound healing
05/18/2011	EP1781622B1 Integrin alpha-v beta-3 antagonists for use in imaging and therapy
05/18/2011	EP1767201B1 Nutrient composition and composition for prevention/mitigation of digestive tract depression
05/18/2011	EP1765350B1 Manufacturing method of solid dispersion containing itraconazole
05/18/2011	EP1753418B1 Compositions comprising nebivolol
05/18/2011	EP1686984B1 Use of c-(2-phenyl-cyclohexyl)-methylamine compounds for the treatment of anxiety disorders
05/18/2011	EP1667984B1 Gamma-secretase inhibitors
05/18/2011	EP1603872B1 S-[2-[(1-iminoethyl)amino]ethyl]-2-methyl-l-cysteine maleate hydrochloride crystalline salt
05/18/2011	EP1589945B1 Topical pharmaceutical and/or cosmetic dispense systems
05/18/2011	EP1581221B1 Substituted tricyclic gamma-carbolines as serotonin receptor agonists and antagonists
05/18/2011	EP1553967B1 Use of amide derivative of ge 2270 factor a3 for the treatment of acne
05/18/2011	EP1539664B1 Crystallization of polyol compositions, crystalline polyol composition product and use thereof
05/18/2011	EP1529053B1 Macrolide compounds endowed with antiinflammatory activity
05/18/2011	EP1467969B1 Dna minor groove binding compounds
05/18/2011	EP1379499B1 New diaminedithiol derivatives and radiorhenium or radiotechnetium complex thereof; a liver cancer-treating composition comprising the radiorhenium complex and lipiodol; and a kit for preparation of the liver cancer-treating composition
05/18/2011	EP1295871B1 Vitamin d derivatives possessing a 22-oxa or 22-thia atom, a c17-side chain substituted by an acid, ester or amide group and a 16(17)-double bond
05/18/2011	EP1268096B9 Extrusion die
05/18/2011	EP1192136B1 Oligomers and polymers of cyclic imino carboxylic acids
05/18/2011	EP1131440B1 Process for oxidising terpenes
05/18/2011	EP0910363B1 Veterinary use of a pleuromutilin derivative
05/18/2011	CN201831370U Electric heating health-care bed
05/18/2011	CN1989986B Chuanxiong rhizome effective ingredient, preparing, preparation method and use thereof
05/18/2011	CN1981833B Medicinal composition of elutriate, virgate wormwood herb and and cape-jasmine
05/18/2011	CN1976685B Oral antimicrobial pharmaceutical compositions
05/18/2011	CN1962684B Triterpene saponin compound, its preparing method and use thereof
05/18/2011	CN1962665B Extraction method of antineoplastic composition bhang flavone A from bhang
05/18/2011	CN1913873B Medical product containing tiotropium incorporated in a waterproof container
05/18/2011	CN1874996B Aminopropanol derivatives
05/18/2011	CN1872080B Drop pills of thevetoside and preparation method
05/18/2011	CN1798831B Compositions comprising lactobacillus plantarum strains in combination with tannin and new lactobacillus plantarum strains
05/18/2011	CN1744821B Methods and application using compounds from fetal cells and tissues to improve condition of skin
05/18/2011	CN1727340B Temozolomide 8-carboxylic ester, and combination
05/18/2011	CN1720225B N-arylsulfonyl-3-substituted indoles having serotonin receptor affinity, process for their preparation and pharmaceutical composition containing them
05/18/2011	CN1700909B Treatment solution and application for preventing posterior capsular opacification by selectively inducing detachment and/or death of lens epithelial cells
05/18/2011	CN1680568B Microbiological coverting product of curcumenol, use and preparation thereof
05/18/2011	CN1665554B Compounds and method for preparing surfaces in a haemocompatible manner
05/18/2011	CN1527704B Compositions and method of administering tubulin binding agents for the treatment of ocular diseases
05/18/2011	CN102066571A Wickerol and process for production thereof
05/18/2011	CN102066398A Antioxidant inflammation modulators: C-17 homologated oleanolic acid derivatives
05/18/2011	CN102066397A Compounds including an anti-inflammatory pharmacore and methods of use
05/18/2011	CN102066396A A simultaneous method for the preparation of a mixture of 3- acetoxy-17-acetamido-16-formyl-androst-5,17-diene and 3- acetoxy-2'-chloro-5-androsteno[17,16-B]pyridine
05/18/2011	CN102066394A Analogues of glycolipids useful as immunoadjuvants
05/18/2011	CN102066385A New peptidomimetic compounds
05/18/2011	CN102066384A Quinuclidine compounds as alpha-7 nicotinic acetylcholine receptor ligands
05/18/2011	CN102066381A Nalmefene prodrugs
05/18/2011	CN102066380A Phenyl-substituted 2-imino-3-methyl pyrrolo pyrimidinone compounds as BACE-1 inhibitors, compositions, and their use
05/18/2011	CN102066379A Imidazo [2,1-b] quinazolin-2-one derivatives and their use as platelet anti-aggregative agents
05/18/2011	CN102066378A 3-(3-pyrimidin-2-yl-benzyl)-[1,2,4]triazolo[4,3-b]pyridazine derivatives as MET kinase inhibitors
05/18/2011	CN102066377A Novel phenylimidazopyrazines
05/18/2011	CN102066376A Anhydrous crystal form of orvepitant maleate
05/18/2011	CN102066375A New trinem antibiotics and inhibitors of beta-lactamases
05/18/2011	CN102066372A 5,6-bicyclic heteroaryl-containing urea compounds as kinase inhibitors
05/18/2011	CN102066371A Aryl-quinolyl compounds and their use
05/18/2011	CN102066370A Novel phenyl-imidazopyridines and pyridazines
05/18/2011	CN102066367A Thiazolyl piperdine derivatives
05/18/2011	CN102066366A Novel substituted pyridin-2-ones and pyridazin-3-ones
05/18/2011	CN102066365A Thiophene or thiazole derivatives and their use as PI3K inhibitors
05/18/2011	CN102066364A Composition of flavanolignan and amino acid with improved water solubility
05/18/2011	CN102066363A A crystalline form of posaconazole
05/18/2011	CN102066360A Quinoline or isoquinoline substituted P2X7 antagonists
05/18/2011	CN102066359A Novel heteroaryl carboxamide derivatives
05/18/2011	CN102066358A CGRP receptor antagonists
05/18/2011	CN102066357A Indoles as modulators of nicotinic acetylcholin receptor subtype alpha-71
05/18/2011	CN102066356A Indoles as modulators of nicoticic acetylcholine receptor subtype alpha-7
05/18/2011	CN102066353A Disubstituted phthalazine Hedgehog pathway antagonists
05/18/2011	CN102066345A Oxazolidine derivatives as NMDA antagonists
05/18/2011	CN102066344A Methods of preparing imidazole-based bicyclic compounds
05/18/2011	CN102066343A Trisubstituted 1, 2, 4 -triazoiies as nicotinic acetylcholine receptor modulators
05/18/2011	CN102066342A Quinoxalinedione derivatives
05/18/2011	CN102066341A Substituted quinazolines
05/18/2011	CN102066340A 2, 6-diamino-pyrimidin- 5-yl-carboxamides as SRK or JAK kinases inhibitors
05/18/2011	CN102066339A 2, 6-diamino- pyrimidin- 5-yl-carboxamides as SYK or JAK kinases inhibitors
05/18/2011	CN102066338A Inhibitors of protein kinases
05/18/2011	CN102066337A 5-hydroxypyrimidine-4-carboxamide compound
05/18/2011	CN102066335A Substituted pyrimidin-5-carboxamides 281

1 ... 1735 1736 1737 1738 1739 1740 1741 1742 1743 1744 1745 1746 1747 1748 1749 1750 1751 1752 1753 1754 1755 ... 7860